Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma
Conditions: Hypopharyngeal Carcinoma; Immunotherapy; Chemotherapy Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: Capecitabine; Drug: Camrelizumab; Drug: Apatinib Sponsor: Eye & ENT Hospital of Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Hypopharyngeal Cancer | Immunotherapy | Research | Taxotere | Xeloda